Use Options For a Chance To Buy ZIOP at a 61% Discount

Looking back to 35 days ago, ZIOPHARM Oncology Inc (ZIOP) priced a 10,000,000 share secondary stock offering at $8.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 48.9% above the offering price..